Free Submission Public Relations & NewsPR-inside.com
Home
Deutsch English

Business

"Isis Pharmaceuticals, Inc. - Strategy and SWOT Report" now available at Fast Market Research


Print article Print article
2014-04-01 16:45:11 - New Business research report from MarketLine is now available from Fast Market Research

Isis Pharmaceuticals, Inc. - Strategy and SWOT Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360deg view of the company.

Features:

* Detailed information on Isis Pharmaceuticals, Inc. required for business and competitor intelligence needs
* A study of the major internal and external factors affecting Isis Pharmaceuticals, Inc. in the form of a SWOT analysis
* An in-depth view of the business model of Isis Pharmaceuticals, Inc. including a breakdown and examination of key business segments
* Intelligence on Isis Pharmaceuticals, Inc.'s mergers and acquisitions (M&A), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors

* News about Isis Pharmaceuticals, Inc., such as business expansion, restructuring, and contract wins
* Large number of easy-to-grasp charts and graphs that present important data and key trends

Full Report Details at
- www.fastmr.com/prod/787937_isis_pharmaceuticals_inc_strategy_and ..

Highlights:

Isis Pharmaceuticals (Isis or 'the company') uses antisense technology, a drug discovery platform, to discover and develop novel drugs for its product pipeline and for its partners. The company primarily operates in the US. It is headquartered in Carlsbad, California, and employed 288 people as of February 11, 2013. The company recorded revenues of $102 million during the financial year ended December 2012 (FY2012), an increase of 3% over FY2011. The operating loss of the company was $68.9 million in FY2012, as compared to an operating loss of $71.1 million in FY2011. The net loss was $65.5 million in FY2012, as compared to a net loss of $84.8 million in FY2011.

Reasons to Purchase:

* Gain understanding of Isis Pharmaceuticals, Inc. and the factors that influence its strategies
* Track strategic initiatives of the company and latest corporate news and actions
* Assess Isis Pharmaceuticals, Inc. as a prospective partner, vendor or supplier
* Support sales activities by understanding your customers' businesses better
* Stay up to date on Isis Pharmaceuticals, Inc.'s business structure, strategy and prospects

Partial Table of Contents:

Company Snapshot
Isis Pharmaceuticals, Inc.: Company Overview
Isis Pharmaceuticals, Inc.: Overview and Key Facts
Isis Pharmaceuticals, Inc.: Overview
Isis Pharmaceuticals, Inc.: Key Facts
Isis Pharmaceuticals, Inc.: Key Employees
Isis Pharmaceuticals, Inc.: Key Employee Biographies
Isis Pharmaceuticals, Inc.: Major Products and Services
Isis Pharmaceuticals, Inc.: Company History
Isis Pharmaceuticals, Inc.: Management Statement
Isis Pharmaceuticals, Inc.: Locations and Subsidiaries
Isis Pharmaceuticals, Inc.: Key Competitors
Isis Pharmaceuticals, Inc.: Company Analysis
Isis Pharmaceuticals, Inc.: Business Description
Isis Pharmaceuticals, Inc.: SWOT Analysis
Isis Pharmaceuticals, Inc.: SWOT Overview
Isis Pharmaceuticals, Inc.: Strengths
Isis Pharmaceuticals, Inc.: Weaknesses
Isis Pharmaceuticals, Inc.: Opportunities
Isis Pharmaceuticals, Inc.: Threats
Isis Pharmaceuticals, Inc.: Corporate Financial Deals Activity
Isis Pharmaceuticals, Inc.: Financial Deals Overview
Isis Pharmaceuticals, Inc.: Targets and Partners
Isis Pharmaceuticals, Inc.: Top Deals 2010 - 2014YTD*
Isis Pharmaceuticals, Inc.: Advisors
Isis Pharmaceuticals, Inc.: Top Financial Advisors
Isis Pharmaceuticals, Inc.: Capital Raising
Isis Pharmaceuticals, Inc.: Partnership
Isis Pharmaceuticals, Inc.: Divestments
Isis Pharmaceuticals, Inc.: Recent Developments
Isis Pharmaceuticals, Inc.: News and Events Summary
Isis Pharmaceuticals, Inc.: Business Expansion
Isis Pharmaceuticals, Inc.: Financial Deals
Isis Pharmaceuticals, Inc.: Financial Performance
Isis Pharmaceuticals, Inc.: Regulatory and Legal Events
Isis Pharmaceuticals, Inc.: Research & Development
Appendix
Contact Us
Methodology
Definitions
About MarketLine

List of Tables

Table 1: Isis Pharmaceuticals, Inc.: Key Facts
Table 2: Isis Pharmaceuticals, Inc.: Key Employees
Table 4: Isis Pharmaceuticals, Inc.: Key Competitors
Table 5: Isis Pharmaceuticals, Inc.: Deal Activity by Deal Type - Volume (TTM*)
Table 6: Isis Pharmaceuticals, Inc.: Deal Activity by Deal Type - Volume (2010 - YTD*2014)
Table 7: Isis Pharmaceuticals, Inc.: Targets and Partners
Table 8: Isis Pharmaceuticals, Inc.: Top Deals 2010 - 2014YTD*
Table 9: Isis Pharmaceuticals, Inc.: Financial Advisor Ranking by Value (US$m)
Table 10: Isis Pharmaceuticals, Inc.: Capital Raising Volume and Value Trend (2010 - YTD*2014)
Table 11: Isis Pharmaceuticals, Inc.: Capital Raising by Deal Type (2010 - YTD*2014)
Table 12: Isis Pharmaceuticals, Inc.: Partnership Volume and Value Trend (2010 - YTD*2014)
Table 13: Isis Pharmaceuticals, Inc.: Partnership Trend by Deal Type (2010 - YTD*2014)
Table 14: Isis Pharmaceuticals, Inc.: Divestments Volume and Value Trend (2010 - YTD*2014)
Table 15: Isis Pharmaceuticals, Inc.: Divestments by Geography (2010 - YTD*2014)
Table 16: Isis Pharmaceuticals, Inc.: News and Events Summary
Table 17: Isis Pharmaceuticals, Inc.: Business Expansion
Table 18: Isis Pharmaceuticals, Inc.: Financial Deals
Table 19: Isis Pharmaceuticals, Inc.: Financial Performance
Table 20: Isis Pharmaceuticals, Inc.: Regulatory and Legal Events
Table 21: Isis Pharmaceuticals, Inc.: Research & Development

List of Figures

Full Table of Contents is available at:
-- www.fastmr.com/catalog/product.aspx?productid=787937&dt=t

About MarketLine

MarketLine is a global publisher of company, industry and country information. Their clients operate across a wide variety of industries and job functions and range from multinational corporations right down to small businesses in both developed and developing economies. MarketLine users enjoy access to content that is trustworthy, up to date and reasonably priced and routinely turn to them as their first-stop resource for instantly accessible, reliable business information. View more research from MarketLine at www.fastmr.com/catalog/publishers.aspx?pubid=1034

About Fast Market Research

Fast Market Research is a leading distributor of market research and business information. Representing the world's top research publishers and analysts, we provide quick and easy access to the best competitive intelligence available. Our unbiased, expert staff is always available to help you find the right research to fit your requirements and your budget.

For more information about these or related research reports, please visit our website at www.fastmr.com or call us at 1.800.844.8156.


Author:
Bill Thompson
e-mail
Web: www.fastmr.com
Phone: 18008448156

Disclaimer: If you have any questions regarding information in these press releases please contact the company added in the press release. Please do not contact pr-inside. We will not be able to assist you. PR-inside disclaims contents contained in this release.
Latest News
Read the Latest News
www.newsenvoy.com

 


Terms & Conditions | Privacy | About us | Contact PR-inside.com